Synapse - Works

Results (6564)

The incidence of symptomatic lower-extremity lymphedema following treatment of uterine corpus malignancies: A 12-year experience at Memorial Sloan-Kettering Cancer Center

Journal Article

Abu-Rustum, N. R.; Alektiar, K.; Iasonos, A.; Lev, G.; Sonoda, Y.; Aghajanian, C.; Chi, D. S.; Barakat, R. R.
Gynecologic Oncology (2006)

Fulltext@MSK | Save

Primary central nervous system lymphoma: The Memorial Sloan-Kettering Cancer Center prognostic model

Journal Article

Abrey, L. E.; Ben-Porat, L.; Panageas, K. S.; Yahalom, J.; Berkey, B.; Curran, W.; Schultz, C.; Leibel, S.; Nelson, D.; Mehta, M.; more...
Journal of Clinical Oncology (2006)

Fulltext@MSK | Save

Adoptive transfer of in vitro generated T cell precursors enhances donor T cell reconstitution and graft-versus-tumor activity in allogeneic hematopoietic stem cell transplantation recipients

Meeting Abstract

Zakrzewski, J. L.; Kochman, A. A.; Lu, S. X.; Terwey, T. H.; Kim, T. D.; Hubbard, V. M.; Muriglan, S. J.; Suh, D.; Cabrera-Perez, J.; Radhakrishnan, R.; more...
Blood (2005)

Fulltext@MSK | Save

Selective use of a rigid prosthesis for chest wall reconstruction after chest wall resection reduces respiratory complication rates

Meeting Abstract

Weyant, M.; Bains, M.; Venkatraman, E.; Downey, R.; Park, B.; Flores, R.; Rusch, V.
Lung Cancer (2005)

Fulltext@MSK | Save

A randomized trial of cytarabine with high-dose mitoxantrone compared to a standard vincristine/prednisone-based regimen as induction therapy for adult patients with ALL

Meeting Abstract

Weiss, M. A.; Heffner, L.; Lamanna, N.; Kalaycio, M.; Schiller, G.; Coutre, S.; Maslak, P.; Jurcic, J.; Panageas, K.; Scheinberg, D. A.
Journal of Clinical Oncology (2005)

Fulltext@MSK | Save

A phase II trial of letrozole in combination with bevacizumab, an anti-VEGF antibody, in patients with hormone receptor-positive metastatic breast cancer

Meeting Abstract

Traina, T. A.; Dickler, M. N.; Caravelli, J. F.; Yeh, B. M.; Brogi, E.; Panageas, K.; Flores, S. A.; Norton, L.; Park, J.; Hudis, C.; more...
Breast Cancer Research and Treatment (2005)

Fulltext@MSK | Save

A feasibility study of an aromatase inhibitor (Al), letrozole (L) and the antibody to vascular endothelial growth factor (VEGF), bevacizurnab (B), in patients (pts) with hormone receptor-positive metastatic breast cancer (MBC)

Meeting Abstract

Traina, T. A.; Dickler, M. N.; Caravelli, J. F.; Yeh, B. M.; Brogi, E.; Panageas, K.; Flores, S. A.; Norton, L.; Hudis, C.; Rugo, H.
Journal of Clinical Oncology (2005)

Fulltext@MSK | Save

Phase II trial of preoperative combined modality therapy for esophageal carcinoma: Induction cisplatin-irinotecan followed by concurrent cisplatinirinotecan and radiotherapy

Meeting Abstract

Tew, W. P.; Minsky, B.; Bains, M.; Rizk, N.; Rusch, V.; Kelsen, D. P.; Shah, M.; Kepler, S.; Gonen, M.; Ilson, D. H.
Journal of Clinical Oncology (2005)

Fulltext@MSK | Save

Predicting non-sentinel node status after positive sentinel lymph node biopsy for breast cancer: Clinicians versus nomogram

Meeting Abstract

Specht, M.; Kattan, M. W.; Gonen, M.; Fey, J.; Van Zee, K. J.
Annals of Surgical Oncology (2005)

Fulltext@MSK | Save

Randomized phase II trial of cetuximab/bevacizumab/irinotecan (CBI) versus cetuximab/bevacizumab (CB) in irinotecan-refractory colorectal cancer

Meeting Abstract

Saltz, L. B.; Lenz, H. J.; Hochster, H.; Wadler, S.; Hoff, P.; Kemeny, N.; Hollywood, E.; Gonen, M.; Wetherbee, S.; Chen, H.
Journal of Clinical Oncology (2005)

Fulltext@MSK | Save